These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12855350)

  • 21. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance.
    Cleeland CS; Nakamura Y; Howland EW; Morgan NR; Edwards KR; Backonja M
    Neuropsychopharmacology; 1996 Sep; 15(3):252-62. PubMed ID: 8873108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.
    Finn JW; Walsh TD; MacDonald N; Bruera E; Krebs LU; Shepard KV
    J Clin Oncol; 1993 May; 11(5):967-72. PubMed ID: 8487059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avinza - 24-h sustained-release oral morphine therapy.
    Caldwell JR
    Expert Opin Pharmacother; 2004 Feb; 5(2):469-72. PubMed ID: 14996642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
    Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
    Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of regularly administered sustained release oral morphine with intramuscular morphine for control of postoperative pain.
    Bourke M; Hayes A; Doyle M; McCarroll M
    Anesth Analg; 2000 Feb; 90(2):427-30. PubMed ID: 10648333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Performance Is Related to Central Sensitization and Health-related Quality of Life in Patients with Chronic Whiplash-Associated Disorders and Fibromyalgia.
    Coppieters I; Ickmans K; Cagnie B; Nijs J; De Pauw R; Noten S; Meeus M
    Pain Physician; 2015; 18(3):E389-401. PubMed ID: 26000686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
    Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
    Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia.
    Rapp SE; Egan KJ; Ross BK; Wild LM; Terman GW; Ching JM
    Anesth Analg; 1996 May; 82(5):1043-8. PubMed ID: 8610865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial.
    Klepstad P; Kaasa S; Jystad A; Hval B; Borchgrevink PC
    Pain; 2003 Jan; 101(1-2):193-8. PubMed ID: 12507714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.
    Schiltenwolf M; Akbar M; Hug A; Pfüller U; Gantz S; Neubauer E; Flor H; Wang H
    Pain Physician; 2014; 17(1):9-20. PubMed ID: 24452649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of intrathecal opioids in chronic non-cancer pain.
    Roberts LJ; Finch PM; Goucke CR; Price LM
    Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
    Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
    BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.
    Kamboj SK; Conroy L; Tookman A; Carroll E; Jones L; Curran HV
    Eur J Pain; 2014 Nov; 18(10):1376-84. PubMed ID: 24700581
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.